Oncorus Inc
ONCR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.29M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.29 Million |
|---|---|
| Enterprise Value | $51.32 Million |
| Annual dividend | $0.14 |
| Dividend yield | 110.58% |
| Earnings per Share | $-3.02 |
| Beta | 1.95 |
| Outstanding Shares | 26,095,000 |
Return
| Return on Equity | -302.90% |
|---|---|
| Return on Assets | -85.89% |
| Return on Invested Capital | -75.37% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.05 |
| Price to Sales | - |
| Price to Book Ratio | 0.13 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.87 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.35 |
| Debt to Equity | 2.23 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Oncorus Inc
56 employees
At Oncorus, the company is focused on driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. Oncorus is advancing a portfolio of intratumorally and intravenously administered viral ...